The CEO's Guide to EBITDA Margin Improvement
A commercial-first EBITDA improvement framework that expands margin without cutting the muscle.
The Operator's Guide to EBITDA Margin Improvement
Every PE thesis has an EBITDA number. Every operating partner has six months before the board asks how the number is tracking. The default instinct is cost reduction, because costs are concrete and cutting them feels like action.
Cost cutting produces real margin. It also has a ceiling, and the ceiling arrives faster than most operating partners expect. This guide covers the commercial levers that keep delivering margin after the cost work runs out of room.
What's at stake
The thesis probably modeled a 3-7 point EBITDA expansion over a 4-5 year hold. At a $40M ARR portco with a starting 20% EBITDA margin, that's roughly $1.2M to $2.8M of annual margin to produce, compounded across the hold.
Most operating partners deliver the first 1-2 points through cost reduction: software consolidation, vendor renegotiation, real estate footprint. After that, the cost budget runs out of muscle-free cuts. The remaining 2-5 points have to come from commercial expansion, and that expansion takes 12-18 months to install.
The portcos that deliver top-quartile EBITDA outcomes at exit start the commercial work early. The portcos that miss the number are still cutting costs in year three, running out of things to cut.
The framework
1. Separate the cost stack from the commercial stack in your first board view
Why it matters. If the EBITDA plan blends cost and commercial levers, the sequencing gets muddled and the board can't see which bets are working.
What to do. Build a two-column plan: cost actions with 12-month impact, commercial actions with 18-36-month impact. Report against both separately.
Common failure mode. A single "EBITDA improvement" bucket that makes every initiative look interchangeable. It isn't; the timelines and risks are different.
2. Start with pocket price, not list price
Why it matters. Every portco has a pocket-price gap. That gap is the sharpest margin recovery move because it doesn't require a price increase, just enforcement of the price already set.
What to do. Pull the last 90 days of billing data. Measure the dollar gap between list and pocket for the top 50 accounts. Install a 10% discount approval threshold.
Common failure mode. Asking the CFO for "a pricing review" and getting a slide about list prices. Pocket price is a different analysis and has to be requested specifically.
3. Fix discounting before raising price
Why it matters. A 5% list price increase absorbed by 6% additional discounting produces net-negative margin. The governance has to precede the raise.
What to do. Install deal desk sign-off. Report pocket price weekly. Hold the CRO accountable for pocket price realization, not just bookings.
Common failure mode. Raising list in the first 120 days to "send a signal," before the governance is in place. The signal gets absorbed by reps protecting quota.
4. Treat NRR as an EBITDA lever, not a CS metric
Why it matters. Every 1 point of NRR (net revenue retention) improvement at a $40M ARR portco produces $400K of annual recurring revenue at near-100% incremental margin. NRR belongs in the EBITDA plan.
What to do. Set an NRR target alongside new-bookings targets. Build a retention scorecard into the monthly operating review. Make the CS leader accountable for NRR, not for "customer health scores."
Common failure mode. Reporting retention as logo retention. Logo retention can stay flat while NRR declines, and the declining NRR is the EBITDA leak.
5. Re-tier packaging to capture value already delivered
Why it matters. Most portcos bundle features at the wrong tier. Enterprise features sit in the Pro tier. Nobody upgrades because the Pro tier already includes what they need.
What to do. Audit feature adoption by tier. Move high-adoption, high-value features to the top tier. Create a clear upgrade path with a quantifiable reason to move.
Common failure mode. Repackaging without usage data. The team rearranges tiers based on intuition and upgrade rates don't move.
6. Govern renewal pricing as aggressively as new sales
Why it matters. Renewals are where quiet margin erosion happens. A three-year renewal with a 12% "loyalty discount" is an EBITDA event that never appears on any dashboard as one.
What to do. Require executive sign-off on renewal discounts above 7%. Report renewal net ACV alongside logo retention. Train account managers to present renewals as value conversations, not discount negotiations.
Common failure mode. Letting account managers handle renewals unsupervised because "they own the relationship." The relationship often costs 8% of margin.
7. Review the EBITDA plan against commercial leading indicators
Why it matters. EBITDA is a trailing metric. By the time the EBITDA result shows up, the commercial decisions that drove it are 6-9 months old.
What to do. Add pocket-price realization, NRR, and pipeline coverage to the monthly operating partner dashboard. Treat drift in the leading indicators as an early EBITDA warning.
Common failure mode. Reviewing EBITDA monthly without the commercial leading indicators alongside. You find out too late to correct.
Diagnostic questions
- What is the dollar gap between list and pocket price across the top 20 accounts?
- How many points of your EBITDA target are committed to commercial levers versus cost?
- What is the trajectory of NRR (net revenue retention) over the last four quarters?
- When was the last renewal discount above 10% that didn't have executive sign-off?
- Does your packaging audit show a quantifiable reason for customers to upgrade?
- Is pocket price realization reported on the same dashboard as bookings?
- Has your cost-reduction program reached the point where further cuts start removing capability?
Immediate next steps
- Pull pocket-price realization for the largest portco and identify the three biggest leakage sources
- Set an NRR target for every portco and add it to the monthly operating partner review
- Audit the last 20 renewals above $100K for unapproved discounts
- Separate the cost stack from the commercial stack in your next board deck
Common mistakes
- Over-indexing on cost in year one. A $70M ARR portco spent 14 months cutting vendor contracts and had no commercial headroom left when growth flattened.
- Assuming NRR is a CS problem. A $30M ARR portco lost 4 points of NRR to churnable customers who were never onboarded properly. The CS team didn't own the first 90 days.
- Raising list before fixing leakage. A $45M ARR portco raised list 6% and saw pocket price decline 2% because reps discounted harder.
- Treating renewals as administrative. A $25M ARR portco quietly lost 9% of renewal ACV to "loyalty discounts" that no single executive approved.
Run the free assessment or book a consultation to apply this framework to your specific situation.
Questions, answered
4 QuestionsWhy is commercial-led EBITDA expansion better than cost-led?
Cost-led expansion is finite. You can only cut so much before you start removing capability. Commercial-led expansion, done through pricing governance and NRR (net revenue retention) improvement, compounds across the hold period. The math: a 1% list-price increase typically drops 8-11% to EBITDA. A 1% cost reduction drops 2-3%. The ceiling on commercial work is much higher.
What's the fastest EBITDA lever in the first six months?
Discount governance. A deal desk threshold at 10%, enforced without exception, typically recovers 2-4% of margin within one quarter. No product change, no list price move, no headcount decision. It's the most effective action an operating partner can take in the first six months.
How do you know if an EBITDA target is commercial or structural?
If the thesis called for EBITDA expansion above 5 points during the hold, at least half of that has to be commercial. Cost alone can't produce 5-point expansion in most mid-market portcos without breaking the operating model. The moment you push past what costs can reasonably deliver, you're implicitly committing to commercial expansion.
What EBITDA moves should operating partners avoid in the first year?
Aggressive list price increases without deal desk governance. Headcount cuts in revenue-generating functions. Cross-selling programs launched before product telemetry is installed. These moves look like EBITDA in the model and show up as revenue loss in the P&L.
A commercial-first EBITDA improvement framework that expands margin without cutting the muscle.
How relevant and useful is this article for you?
About the Author(s)
Emily Ellis is the Founder of FintastIQ. Emily has 20 years of experience leading pricing, value creation, and commercial transformation initiatives for PE portfolio companies and high-growth businesses. She has previous experience as a leader at McKinsey and BCG and is the Founder of FintastIQ and the Growth Operating System.
References
- William Thorndike. The Outsiders. Harvard Business Review Press, 2012
- Eileen Appelbaum & Rosemary Batt. Private Equity at Work. Russell Sage Foundation, 2014
- Michael Marn, Eric Roegner & Craig Zawada. The Price Advantage. Wiley, 2004
- Bain & Company. Global Private Equity Report. Bain & Company, 2024
- McKinsey & Company. The Power of Pricing. McKinsey Quarterly, 2003